- Home
- DRIO vs KAPA Comparison
DRIO vs KAPA Comparison
Compare DRIO & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- KAPA
- Stock Information
- Founded
- DRIO 2011
- KAPA 2013
- Country
- DRIO United States
- KAPA United States
- Employees
- DRIO N/A
- KAPA N/A
- Industry
- DRIO Medical/Dental Instruments
- KAPA
- Sector
- DRIO Health Care
- KAPA
- Exchange
- DRIO Nasdaq
- KAPA NYSE
- Market Cap
- DRIO 25.1M
- KAPA 20.2M
- IPO Year
- DRIO N/A
- KAPA 2024
- Fundamental
- Price
- DRIO $0.80
- KAPA $1.60
- Analyst Decision
- DRIO Strong Buy
- KAPA Strong Buy
- Analyst Count
- DRIO 1
- KAPA 1
- Target Price
- DRIO $4.00
- KAPA $9.00
- AVG Volume (30 Days)
- DRIO 169.0K
- KAPA 92.8K
- Earning Date
- DRIO 11-07-2024
- KAPA 11-14-2024
- Dividend Yield
- DRIO N/A
- KAPA N/A
- EPS Growth
- DRIO N/A
- KAPA N/A
- EPS
- DRIO N/A
- KAPA N/A
- Revenue
- DRIO $23,052,000.00
- KAPA N/A
- Revenue This Year
- DRIO $34.56
- KAPA N/A
- Revenue Next Year
- DRIO $39.35
- KAPA N/A
- P/E Ratio
- DRIO N/A
- KAPA N/A
- Revenue Growth
- DRIO N/A
- KAPA N/A
- 52 Week Low
- DRIO $0.65
- KAPA $1.22
- 52 Week High
- DRIO $2.60
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- DRIO 52.51
- KAPA N/A
- Support Level
- DRIO $0.65
- KAPA N/A
- Resistance Level
- DRIO $0.80
- KAPA N/A
- Average True Range (ATR)
- DRIO 0.06
- KAPA 0.00
- MACD
- DRIO 0.01
- KAPA 0.00
- Stochastic Oscillator
- DRIO 83.33
- KAPA 0.00
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.